UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review

CNS drugs, 2014-05, Vol.28 (5), p.421-453

2014

Volltextzugriff (PDF)

C.02.01 Efficacy and tolerability of antipsychotic treatment

European neuropsychopharmacology, 2014-10, Vol.24, p.S752-S753

Peuskens, J

2014

Volltextzugriff (PDF)

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

Acta psychiatrica Scandinavica, 2016-01, Vol.133 (1), p.5-22

2016

Volltextzugriff (PDF)

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

British journal of psychiatry, 2011-08, Vol.199 (2), p.99-105

2011

Volltextzugriff (PDF)

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects

Journal of affective disorders, 2010-04, Vol.122 (1), p.60-67

2010

Volltextzugriff (PDF)

Second-generation antipsychotics and constipation: A review of the literature

European psychiatry, 2011-01, Vol.26 (1), p.34-44

2011

Volltextzugriff (PDF)

How are we assessing functioning in schizophrenia? A need for a consensus approach

European psychiatry, 2012-08, Vol.27 (6), p.391-395

2012

Volltextzugriff (PDF)

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy

Journal of affective disorders, 2009-07, Vol.116 (1), p.106-112

2009

Volltextzugriff (PDF)

Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study

Schizophrenia research, 2013-06, Vol.147 (1), p.132-139

2013

Volltextzugriff (PDF)

No gender differences in social outcome in patients suffering from schizophrenia

European psychiatry, 2012-08, Vol.27 (6), p.406-408

2012

Volltextzugriff (PDF)

Standardized remission criteria in schizophrenia

Acta psychiatrica Scandinavica, 2006-02, Vol.113 (2), p.91-95

2006

Volltextzugriff (PDF)

Setting new standards in schizophrenia outcomes: Symptomatic remission 3 years before versus after the andreasen criteria

European psychiatry, 2012-04, Vol.27 (3), p.170-175

2012

Volltextzugriff (PDF)

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

Clinical practice and epidemiology in mental health, 2006-06, Vol.2 (1), p.14-14

2006

Volltextzugriff (PDF)

C.10.02 Can switching to depots improve antipsychotic maintenance treatment?

European neuropsychopharmacology, 2008, Vol.18, p.S598-S598

Peuskens, J

2008

Volltextzugriff (PDF)

P.3.c.001 Outcome of the sertindole cohort prospective (SCoP) study: all-cause mortality

European neuropsychopharmacology, 2008, Vol.18, p.S404-S405

Peuskens, J

2008

Volltextzugriff (PDF)

Physical health management in psychiatric settings

European psychiatry, 2010-06, Vol.25 (S2), p.S22-S28

2010

Volltextzugriff (PDF)

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

Current medical research and opinion, 2009-09, Vol.25 (9), p.2197-2206

2009

Volltextzugriff (PDF)

A study of the family burden of 150 family members of schizophrenic patients

European psychiatry, 2004-11, Vol.19 (7), p.395-401

2004

Volltextzugriff (PDF)

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

Acta psychiatrica Scandinavica, 1997-10, Vol.96 (4), p.265-273

1997

Volltextzugriff (PDF)

Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial

Schizophrenia bulletin, 2011-03, Vol.37 (2), p.352-361

2011

Volltextzugriff (PDF)

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries

Current medical research and opinion, 2010-03, Vol.26 (3), p.501-509

2010

Volltextzugriff (PDF)

State anxiety and subjective well-being responses to acute bouts of aerobic exercise in patients with depressive and anxiety disorders

British journal of sports medicine, 2009-09, Vol.43 (10), p.756-759

2009

Volltextzugriff (PDF)

Electroconvulsive therapy in Belgium: A nationwide survey on the practice of electroconvulsive therapy

Journal of affective disorders, 2006, Vol.90 (1), p.67-71

2006

Volltextzugriff (PDF)

The prevention of deep venous thrombosis in physically restrained patients with schizophrenia

International journal of clinical practice (Esher), 2010-07, Vol.64 (8), p.1109-1115

2010

Volltextzugriff (PDF)

Mortality in patients with schizophrenia

The Lancet (British edition), 2009-11, Vol.374 (9701), p.1591-1591

2009

Volltextzugriff (PDF)

1 – 25 von 343

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(272)

Publikationsform

Artikel
(333)
Webseiten
(10)

Erscheinungsjahr

n.n

Thema

Psychiatry
(150)
Science & Technology
(134)
Life Sciences & Biomedicine
(132)
Humans
(126)
Schizophrenia
(91)
Female
(88)
Adult
(85)
Biological And Medical Sciences
(84)
Male
(83)
Medical Sciences
(80)
Psychology. Psychoanalysis. Psychiatry
(78)
Psychopathology. Psychiatry
(61)
Schizophrenia - Drug Therapy
(57)
Antipsychotic Agents - Therapeutic Use
(47)
Adult And Adolescent Clinical Studies
(45)
Internal Medicine
(45)
Middle Aged
(41)
Pharmacology. Drug Treatments
(40)
Psychoses
(38)
Neuropharmacology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review

C.02.01 Efficacy and tolerability of antipsychotic treatment

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects

Second-generation antipsychotics and constipation: A review of the literature

How are we assessing functioning in schizophrenia? A need for a consensus approach

Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy

Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study

No gender differences in social outcome in patients suffering from schizophrenia

Standardized remission criteria in schizophrenia

Setting new standards in schizophrenia outcomes: Symptomatic remission 3 years before versus after the andreasen criteria

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

C.10.02 Can switching to depots improve antipsychotic maintenance treatment?

P.3.c.001 Outcome of the sertindole cohort prospective (SCoP) study: all-cause mortality

Physical health management in psychiatric settings

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

A study of the family burden of 150 family members of schizophrenic patients

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries

State anxiety and subjective well-being responses to acute bouts of aerobic exercise in patients with depressive and anxiety disorders

Electroconvulsive therapy in Belgium: A nationwide survey on the practice of electroconvulsive therapy

The prevention of deep venous thrombosis in physically restrained patients with schizophrenia

Mortality in patients with schizophrenia

Aktive Filter

Suchergebnisse filtern